Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -4.24% |
|
-1.86% | -14.13% |
05-21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
05-13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
Sales 2024 * | 66.9M 5.27B | Sales 2025 * | 82.78M 6.52B | Capitalization | 229M 18.07B |
---|---|---|---|---|---|
Net income 2024 * | -44M -3.47B | Net income 2025 * | -38M -3B | EV / Sales 2024 * | 3.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.77 x |
P/E ratio 2024 * |
-4.33
x | P/E ratio 2025 * |
-5.96
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.9% |
Latest transcript on Biodesix, Inc.
1 day | -4.24% | ||
1 week | -1.86% | ||
Current month | +10.49% | ||
1 month | +8.97% | ||
3 months | +9.72% | ||
6 months | -8.67% | ||
Current year | -14.13% |
![Extreme 1.46](/images/extremecours_fleche.png)
![Extreme 1.2](/images/extremecours_fleche.png)
![Extreme 1.15](/images/extremecours_fleche.png)
![Extreme 1.03](/images/extremecours_fleche.png)
![Extreme 0.955](/images/extremecours_fleche.png)
![Extreme 0.955](/images/extremecours_fleche.png)
![Extreme 0.955](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 28/02/11 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 31/05/08 |
Jack Schuler
BRD | Director/Board Member | 83 | 31/12/11 |
Jon Kayyem
BRD | Director/Board Member | 60 | 05/12/21 |
Date | Price | Change | Volume |
---|---|---|---|
25/06/24 | 1.58 | -4.24% | 127,856 |
24/06/24 | 1.65 | -3.51% | 286,754 |
21/06/24 | 1.71 | +6.21% | 1,469,757 |
20/06/24 | 1.61 | 0.00% | 124,942 |
18/06/24 | 1.61 | 0.00% | 144,759 |
Delayed Quote Nasdaq, June 25, 2024 at 09:00 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.13% | 229M | |
-18.45% | 8.53B | |
+65.89% | 4.26B | |
+6.23% | 2.71B | |
-1.93% | 2.63B | |
-57.14% | 1.72B | |
-19.16% | 1.67B | |
-20.01% | 1.45B | |
+15.38% | 1.19B | |
-50.40% | 1.01B |
- Stock Market
- Equities
- BDSX Stock